Dymon Asia Capital (Singapore)’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,983
Closed -$916K 113
2022
Q3
$916K Sell
4,983
-3,825
-43% -$762K 0.22% 74
2022
Q2
$1.48M Buy
+8,808
New +$1.89M 0.11% 72

Other funds holding HCA

Dymon Asia Capital (Singapore)'s HCA Position: Q4 2022 in Review

Dymon Asia Capital (Singapore) sold out of HCA Healthcare (HCA) in Q4 2022, closing a stake of 4,983 shares — an estimated $916K sold.

Dymon Asia Capital (Singapore) first reported a position in HCA in Q2 2022 and held it in 2 quarters. The position peaked at $1.48M in Q2 2022. 962 funds tracked by Wall St. Rank hold HCA as of Q4 2022.

  • Dymon Asia Capital (Singapore) reported no remaining HCA Healthcare position as of Q4 2022 after selling out during the quarter.
  • Dymon Asia Capital (Singapore) sold 4,983 HCA Healthcare shares in Q4 2022, an estimated $916K.
  • Dymon Asia Capital (Singapore) first reported a position in HCA Healthcare in Q2 2022 and held it in 2 quarters.
  • Dymon Asia Capital (Singapore)'s HCA Healthcare position peaked at $1.48M in Q2 2022.
  • 962 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2022.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q4 2022, filed 13 Feb 2023.